GSK milestone adds $14M to cash reserves. Vandana Singh Zymeworks in Focus for Insider Activity: Catalysts Ahead Zymeworks (NYSE:ZYME) came into focus in late December when major shareholder EcoR1 ...

Zymeworks Inc (NASDAQ:ZYME) reported a significant increase in revenue for Q1 2025, reaching $27.1 million compared to $10 million in the same period in 2024. The company achieved a decrease in net ...

VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

$ZYME insiders have traded $ZYME stock on the open market 27 times in the past 6 months. Of those trades, 22 have been purchases and 5 have been sales. Here’s a ...